SOPHiA GENETICS

company

About

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

  • 251 - 500

Details

Last Funding Type
Series F
Last Funding Money Raised
$110M
Industries
Artificial Intelligence,Big Data,Bioinformatics,Biotechnology,Genetics,Health Care,Life Science,Medical
Founded date
Jan 1, 2011
Number Of Employee
251 - 500
Operating Status
Active

SOPHiA GENETICS is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It is the creator of the SOPHiA DDM™ Platform, a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The SOPHiA DDM™ Platform and related solutions, products and services are currently used by more than 780 hospital, laboratory and biopharma institutions globally.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$217M
SOPHiA GENETICS has raised a total of $217M in funding over 2 rounds. Their latest funding was raised on Oct 1, 2020 from a Series F round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 1, 2020 Series F $110M 2 Detail
Jan 4, 2019 Series E $77M 1 Detail
Sep 13, 2017 Series D $30M 1 Detail

Investors

Number of Lead Investors
Number of Investors
3
SOPHiA GENETICS is funded by 3 investors. Era Funding Administration and ACE & Company are the most recent investors.
Investor Name Lead Investor Funding Round
Era Funding Administration Series F
ACE & Company Series F
Alychlo Series E